{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:09:21Z","timestamp":1791864561370,"version":"4.3.4"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.humpath.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T02:35:17Z","timestamp":1678329317000},"page":"39-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Merkel cell carcinoma: an update"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-0216","authenticated-orcid":false,"given":"Ryan C.","family":"DeCoste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thai Yen","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennette R.","family":"Gruchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P.","family":"Nicolela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2023.03.004_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archderm.1972.01620040075020","article-title":"Trabecular carcinoma of the skin","volume":"105","author":"Toker","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib2","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/1097-0142(197811)42:5<2311::AID-CNCR2820420531>3.0.CO;2-L","article-title":"Trabecular carcinoma of the skin. An ultrastructural study","volume":"42","author":"Tang","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib3","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3390\/cancers13112625","article-title":"Virus-driven carcinogenesis","volume":"13","author":"Hatano","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2023.03.004_bib4","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.humpath.2023.03.004_bib5","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/s41379-019-0288-7","article-title":"Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinoma","volume":"32","author":"Kervarrec","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/s41388-017-0073-3","article-title":"Are there multiple cells of origin of Merkel cell carcinoma?","volume":"37","author":"Sunshine","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2023.03.004_bib7","article-title":"Merkel cell carcinoma","volume":"3","author":"Becker","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.humpath.2023.03.004_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2017.10.028","article-title":"Merkel cell carcinoma: current US incidence and projected increases based on changing demographics","volume":"78","author":"Paulson","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40425-018-0404-0","article-title":"Multidimensional, quantitative assessment of PD-1\/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab","volume":"6","author":"Giraldo","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib10","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2023.03.004_bib11","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41571-018-0103-2","article-title":"The biology and treatment of Merkel cell carcinoma: current understanding and research priorities","volume":"15","author":"Harms","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejca.2016.10.022","article-title":"Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs","volume":"71","author":"Schadendorf","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jamadermatol.2020.4102","article-title":"Assessment of age, period, and birth cohort effects and trends in merkel cell carcinoma incidence in the United States","volume":"157","author":"Jacobs","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00262-017-2099-3","article-title":"Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC","volume":"67","author":"Becker","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.humpath.2023.03.004_bib16","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1158\/1055-9965.EPI-05-0895","article-title":"Merkel cell carcinoma and multiple primary cancers","volume":"15","author":"Howard","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.humpath.2023.03.004_bib17","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1158\/0008-5472.CAN-15-0702","article-title":"The distinctive mutational spectra of polyomavirus-negative merkel cell carcinoma","volume":"75","author":"Harms","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib18","article-title":"Merkel cell carcinoma: an updated review of pathogenesis, diagnosis, and treatment options","volume":"35","author":"Hernandez","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.humpath.2023.03.004_bib19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/ijc.24509","article-title":"Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays","volume":"125","author":"Tolstov","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1128\/CVI.05175-11","article-title":"Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus","volume":"18","author":"Viscidi","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.humpath.2023.03.004_bib21","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1158\/1078-0432.CCR-10-3363","article-title":"Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma","volume":"17","author":"Sihto","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.chom.2013.06.008","article-title":"Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7","volume":"14","author":"Kwun","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.humpath.2023.03.004_bib23","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1128\/JVI.02916-13","article-title":"High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens","volume":"88","author":"Borchert","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.humpath.2023.03.004_bib24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1073\/pnas.1818798116","article-title":"Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response","volume":"116","author":"Park","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humpath.2023.03.004_bib25","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1158\/0008-5472.CAN-15-1877","article-title":"UV-associated mutations underlie the etiology of MCV-negative merkel cell carcinomas","volume":"75","author":"Wong","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib26","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/modpathol.2015.60","article-title":"Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma","volume":"28","author":"Pulitzer","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib27","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.18632\/oncotarget.6494","article-title":"Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy","volume":"7","author":"Goh","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2023.03.004_bib28","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41379-022-01151-2","article-title":"RB1-deficient squamous cell carcinoma: the proposed source\u00a0of combined Merkel cell carcinoma","volume":"35","author":"DeCoste","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13073-020-00727-4","article-title":"Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma","volume":"12","author":"Starrett","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.humpath.2023.03.004_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/modpathol.2015.154","article-title":"Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation","volume":"29","author":"Harms","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.humpath.2017.10.014","article-title":"Genetic profiles of different subsets of Merkel cell carcinoma show links between combined and pure MCPyV-negative tumors","volume":"71","author":"Carter","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamadermatol.2017.0507","article-title":"Molecular profiling of multiple primary merkel cell carcinoma to distinguish genetically distinct tumors from clonally related metastases","volume":"153","author":"Harms","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib33","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.humpath.2012.04.002","article-title":"Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma","volume":"43","author":"Higaki-Mori","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/hupa.2001.25904","article-title":"Primary neuroendocrine (Merkel cell) carcinoma of the skin: morphologic diversity and implications thereof","volume":"32","author":"Walsh","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000372-199712000-00011","article-title":"Primary cutaneous neuroendocrine (Merkel cell) carcinoma in association with squamous- and basal-cell carcinoma","volume":"19","author":"Cerroni","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib36","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41379-021-00928-1","article-title":"Genomic evidence suggests that cutaneous neuroendocrine carcinomas can arise from squamous dysplastic precursors","volume":"35","author":"Harms","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jid.2021.07.175","article-title":"Merkel cell polyomavirus\u2012negative merkel cell carcinoma originating from in situ squamous cell carcinoma: a keratinocytic tumor with neuroendocrine differentiation","volume":"142","author":"Kervarrec","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib38","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-0560.2012.01908.x","article-title":"Combined intraepidermal neuroendocrine (Merkel cell) and squamous cell carcinoma in situ with CM2B4 negativity and p53 overexpression","volume":"39","author":"Tan","year":"2012","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/cup.13910","article-title":"Merkel cell carcinoma: a review","volume":"48","author":"Walsh","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.path.2017.01.013","article-title":"Merkel cell carcinoma","volume":"10","author":"Pulitzer","year":"2017","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.humpath.2023.03.004_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cll.2017.05.004","article-title":"Update on merkel cell carcinoma","volume":"37","author":"Harms","year":"2017","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.humpath.2023.03.004_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","article-title":"Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features","volume":"58","author":"Heath","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib43","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","article-title":"Analysis of prognostic factors from 9387 merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system","volume":"23","author":"Harms","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib44","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/PAS.0b013e318236a9b0","article-title":"Absence of Merkel cell polyomavirus in primary parotid high-grade neuroendocrine carcinomas regardless of cytokeratin 20 immunophenotype","volume":"35","author":"Chernock","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0000000000001231","article-title":"UV signature mutations reclassify salivary high-grade neuroendocrine carcinomas as occult metastatic cutaneous merkel cell carcinomas","volume":"43","author":"Sun","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.currproblcancer.2010.02.002","article-title":"Merkel cell carcinoma: pathologic findings and prognostic factors","volume":"34","author":"McCardle","year":"2010","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.anndiagpath.2006.10.001","article-title":"The Toker tumor: spectrum of morphologic features in primary neuroendocrine carcinomas of the skin (Merkel cell carcinoma)","volume":"10","author":"Plaza","year":"2006","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00000478-199206000-00006","article-title":"Pagetoid intraepidermal spread in Merkel cell (primary neuroendocrine) carcinoma of the skin","volume":"16","author":"LeBoit","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib49","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0190-9622(87)70151-0","article-title":"Epidermotropic primary neuroendocrine (Merkel cell) carcinoma of the skin with Pautrier-like microabscesses. Report of three cases and review of the literature","volume":"16","author":"Rocamora","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00000372-200002000-00013","article-title":"Intraepidermal Merkel cell carcinoma with no dermal involvement","volume":"22","author":"Brown","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib51","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/cncr.23874","article-title":"Merkel cell carcinoma: histologic features and prognosis","volume":"113","author":"Andea","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib52","first-page":"334","article-title":"Neuroendocrine (Merkel) cells of the skin: hyperplasias, dysplasias, and neoplasms","volume":"52","author":"Gould","year":"1985","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2023.03.004_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/983421","article-title":"Histological, immunohistological, and clinical features of Merkel cell carcinoma in correlation to Merkel cell polyomavirus status","volume":"2012","author":"Jaeger","year":"2012","journal-title":"J Skin Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib54","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.humpath.2010.09.011","article-title":"Association of Merkel cell polyomavirus infection with morphologic differences in Merkel cell carcinoma","volume":"42","author":"Kuwamoto","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cup.13583","article-title":"Large-cell variant of Merkel cell carcinoma with clear-cell change","volume":"47","author":"Khanna","year":"2020","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib56","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.humpath.2014.12.001","article-title":"Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load","volume":"46","author":"Leroux-Kozal","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/DAD.0b013e3181e3ceb9","article-title":"Primary cutaneous neuroendocrine carcinoma within a cystic trichoblastoma: a nonfortuitous association?","volume":"33","author":"Battistella","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib58","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jid.2019.09.026","article-title":"Polyomavirus-positive merkel cell carcinoma derived from a trichoblastoma suggests an epithelial origin of this merkel cell carcinoma","volume":"140","author":"Kervarrec","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/cup.12468","article-title":"Merkel cell carcinoma arising within a poroma: report of two cases","volume":"42","author":"Molina-Ruiz","year":"2015","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2022.07.021","article-title":"Morphological patterns of metastases from combined Merkel cell carcinomas: study of an eastern Canadian cohort of cases","volume":"129","author":"Gruchy","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaad.2017.12.001","article-title":"Merkel cell carcinoma: an update and review: pathogenesis, diagnosis, and staging","volume":"78","author":"Coggshall","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000018454","article-title":"Differentiation between merkel cell carcinoma and malignant melanoma: an immunohistochemical study","volume":"201","author":"Kontochristopoulos","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.humpath.2023.03.004_bib63","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0560.1991.tb00139.x","article-title":"Epidermotropic neuroendocrine carcinoma. Immunohistochemical differentiation from simulators, including malignant melanoma","volume":"18","author":"Gillham","year":"1991","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib64","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/DAD.0000000000000806","article-title":"Carcinoid-like\/labyrinthine pattern in sebaceous neoplasms represents a sebaceous mantle phenotype: immunohistochemical analysis of aberrant Vimentin expression and cytokeratin 20-positive merkel cell distribution","volume":"39","author":"Goto","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1385\/EP:15:3:247","article-title":"Cdx2 as a marker for neuroendocrine tumors of unknown primary sites","volume":"15","author":"Erickson","year":"2004","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00000372-199808000-00004","article-title":"Cytokeratin and neurofilament protein staining in Merkel cell carcinoma of the small cell type and small cell carcinoma of the lung","volume":"20","author":"Schmidt","year":"1998","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejca.2022.03.043","article-title":"Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022","volume":"171","author":"Gauci","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.dad.0000183701.67366.c7","article-title":"Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung","volume":"28","author":"Bobos","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib69","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00000478-199702000-00014","article-title":"Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites","volume":"21","author":"Chan","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib70","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/his.13758","article-title":"Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma","volume":"74","author":"Stanoszek","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.03.004_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0560.2010.01567_1.x","article-title":"Paranuclear dots of neurofilament reliably identify Merkel cell carcinoma","volume":"37","author":"McCalmont","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib72","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41379-018-0155-y","article-title":"Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas","volume":"32","author":"Kervarrec","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.anndiagpath.2019.04.002","article-title":"A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: evaluation of 24 cases","volume":"40","author":"Leblebici","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib74","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/PAS.0000000000001136","article-title":"INSM1 is more sensitive and interpretable than conventional immunohistochemical stains used to diagnose merkel cell carcinoma","volume":"42","author":"Lilo","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib75","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/PAS.0b013e3181aa30a5","article-title":"Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas","volume":"33","author":"Busam","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib76","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.humpath.2010.12.013","article-title":"Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population","volume":"42","author":"Paik","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib77","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.humpath.2011.06.005","article-title":"The spectrum of Merkel cell polyomavirus expression in Merkel cell carcinoma, in a variety of cutaneous neoplasms, and in neuroendocrine carcinomas from different anatomical sites","volume":"43","author":"Ly","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib78","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jid.2016.10.028","article-title":"Polyomavirus-negative merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multimodal tumor virus detection","volume":"137","author":"Moshiri","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib79","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1600-0560.2012.01964.x","article-title":"Immunohistochemical prognostication of Merkel cell carcinoma: p63 expression but not polyomavirus status correlates with outcome","volume":"39","author":"Hall","year":"2012","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/PAT.0000000000000069","article-title":"Merkel cell polyomavirus and p63 status in Merkel cell carcinoma by immunohistochemistry: merkel cell polyomavirus positivity is inversely correlated with sun damage, but neither is correlated with outcome","volume":"46","author":"Dabner","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2023.03.004_bib81","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1158\/1078-0432.CCR-20-0864","article-title":"Virus-positive merkel cell carcinoma is an independent prognostic group with distinct predictive biomarkers","volume":"27","author":"Harms","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib82","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1172\/JCI64116","article-title":"Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus","volume":"122","author":"Rodig","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humpath.2023.03.004_bib83","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/modpathol.2014.148","article-title":"Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus","volume":"28","author":"Miner","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib84","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.humpath.2018.07.022","article-title":"Immunohistochemical profiles of different subsets of Merkel cell carcinoma","volume":"82","author":"Pasternak","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib85","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1600-0560.2007.00759.x","article-title":"A case series and immunophenotypic analysis of CK20-\/CK7+ primary neuroendocrine carcinoma of the skin","volume":"34","author":"Calder","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.humpath.2021.08.003","article-title":"Relationship between p63 and p53 expression in Merkel cell carcinoma and corresponding abnormalities in TP63 and TP53: a study and a proposal","volume":"117","author":"DeCoste","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib87","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.humpath.2015.05.008","article-title":"Pure versus combined Merkel cell carcinomas: immunohistochemical evaluation of cellular proteins (p53, Bcl-2, and c-kit) reveals significant overexpression of p53 in combined tumors","volume":"46","author":"Lai","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib88","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/01.pas.0000155162.33044.4f","article-title":"B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in merkel cell carcinoma and small cell carcinomas","volume":"29","author":"Dong","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib89","first-page":"142","article-title":"Immunohistochemical expression of PAX5 and TdT by Merkel cell carcinoma and pulmonary small cell carcinoma: a potential diagnostic pitfall but useful discriminatory marker","volume":"6","author":"Kolhe","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib90","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/modpathol.3800936","article-title":"TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis","volume":"20","author":"Sur","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib91","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1111\/jdv.16482","article-title":"BerEP4 positivity in Merkel cell carcinoma: a potential diagnosis pitfall","volume":"34","author":"Kervarrec","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.humpath.2023.03.004_bib92","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/cncr.22828","article-title":"p63 expression as a new prognostic marker in Merkel cell carcinoma","volume":"110","author":"Asioli","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib93","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.humpath.2020.01.001","article-title":"p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved","volume":"97","author":"Walsh","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib94","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1309\/AJCPE4PK6CTBNQJY","article-title":"p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility","volume":"140","author":"Stetsenko","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib95","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.humpath.2013.12.008","article-title":"Support for p63 expression as an adverse prognostic marker in Merkel cell carcinoma: report on a Canadian cohort","volume":"45","author":"Fleming","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib96","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/modpathol.2011.100","article-title":"Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas","volume":"24","author":"Asioli","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib97","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1111\/ajd.13211","article-title":"A Systematic review and Meta-Analysis of the survival and clinicopathological features of p63 expression in Merkel cell carcinoma","volume":"61","author":"Portilla","year":"2020","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib98","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cup.13790","article-title":"Expression of p16 in Merkel cell carcinoma","volume":"48","author":"Talsma","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib99","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/jid.2008.365","article-title":"Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc","volume":"129","author":"Paulson","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1684\/ejd.2021.4170","article-title":"Merkel cell carcinoma: an updated overview of clinico-pathological aspects, molecular genetics and therapy","volume":"31","author":"Dika","year":"2021","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib101","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00403-020-02107-9","article-title":"Current concepts and approaches to merkel cell carcinoma","volume":"313","author":"Babadzhanov","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib102","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41379-020-0571-7","article-title":"Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes","volume":"33","author":"Lazo de la Vega","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib103","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/cancers10110443","article-title":"MiR-375 regulation of LDHB plays distinct roles in polyomavirus-positive and -negative merkel cell carcinoma","volume":"10","author":"Kumar","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2023.03.004_bib104","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1172\/JCI68760","article-title":"Multicolor microRNA FISH effectively differentiates tumor types","volume":"123","author":"Renwick","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humpath.2023.03.004_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/289548","article-title":"Characterization of the merkel cell carcinoma miRNome","volume":"2014","author":"Ning","year":"2014","journal-title":"J Skin Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib106","article-title":"MicroRNAs as potential biomarkers in merkel cell carcinoma","volume":"19","author":"Konstatinell","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2023.03.004_bib107","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaad.2017.12.004","article-title":"Merkel cell carcinoma: an update and review: current and future therapy","volume":"78","author":"Tello","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib108","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/cup.13372","article-title":"The expression of terminal deoxynucleotidyl transferase and paired box gene 5 in Merkel cell carcinomas and its relation to the presence of Merkel cell polyomavirus DNA","volume":"46","author":"Johansson","year":"2019","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib109","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/15321819.2017.1331170","article-title":"Neuroendocrine differentiation in basal cell carcinoma","volume":"38","author":"Houcine","year":"2017","journal-title":"J Immunoassay Immunochem"},{"key":"10.1016\/j.humpath.2023.03.004_bib110","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1600-0560.2006.00674.x","article-title":"Merkel cell carcinoma frequently shows histologic features of basal cell carcinoma: a study of 30 cases","volume":"34","author":"Ball","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib111","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/cup.13051","article-title":"Primary large cell neuroendocrine carcinoma of the skin: an under-recognized entity and a mimic of metastatic disease","volume":"45","author":"Lano","year":"2018","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib112","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1066896913516672","article-title":"Primary carcinoid tumor of the skin: a literature review","volume":"22","author":"Jedrych","year":"2014","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib113","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13000-015-0302-4","article-title":"Unusual apocrine carcinoma with neuroendocrine differentiation: a cutaneous neoplasm may be analogous to neuroendocrine carcinoma with apocrine differentiation of breast","volume":"10","author":"Li","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib114","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/cup.14085","article-title":"Independent primary cutaneous and mammary apocrine carcinomas with neuroendocrine differentiation: report of a case and literature review","volume":"48","author":"DeCoste","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib115","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4103\/ijo.IJO_1745_18","article-title":"Endocrine mucin-producing sweat gland carcinoma (EMPSGC) of the eyelid: clinicopathologic features, immunohistochemical findings and review of literature","volume":"67","author":"Mulay","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.humpath.2023.03.004_bib116","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/cup.13983","article-title":"Endocrine mucin-producing sweat gland carcinoma and associated primary cutaneous mucinous carcinoma: review of the literature","volume":"48","author":"Au","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib117","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/PAI.0b013e318273a9e0","article-title":"Study of EWS\/FLI-1 rearrangement in 18 cases of CK20+\/CM2B4+ Merkel cell carcinoma using FISH and correlation to the differential diagnosis of Ewing sarcoma\/peripheral neuroectodermal tumor","volume":"21","author":"Fernandez-Flores","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2023.03.004_bib118","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/cup.12747","article-title":"Primary cutaneous ewing sarcoma with ewsr1-erg fusion","volume":"43","author":"Molina-Ruiz","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib119","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/jclinpath-2018-205504","article-title":"Update on eighth edition American Joint Committee on Cancer classification for Merkel cell carcinoma and histopathological parameters that determine prognosis","volume":"72","author":"Trinidad","year":"2019","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib120","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/1078-0432.CCR-17-1678","article-title":"Merkel cell carcinoma patients presenting without a primary lesion have elevated markers of immunity, higher tumor mutation burden, and improved survival","volume":"24","author":"Vandeven","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib121","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0194599811431789","article-title":"Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma","volume":"146","author":"Smith","year":"2012","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.humpath.2023.03.004_bib122","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/jid.2012.388","article-title":"Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage","volume":"133","author":"Paulson","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib123","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ajcp\/aqaa017","article-title":"TdT expression is a marker of better survival in merkel cell carcinoma, and expression of B-cell markers is associated with merkel cell polyomavirus","volume":"154","author":"Hoang","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib124","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1158\/1078-0432.CCR-11-3020","article-title":"Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study","volume":"18","author":"Sihto","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib125","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2010.30.6308","article-title":"Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival","volume":"29","author":"Paulson","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib126","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/DAD.0b013e31815c932a","article-title":"Mast cells have prognostic value in Merkel cell carcinoma","volume":"30","author":"Beer","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib127","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/DAD.0b013e318172364d","article-title":"Vascular density has prognostic value in Merkel cell carcinoma","volume":"30","author":"Ng","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1158\/0008-5472.CAN-17-1803","article-title":"Distinct TP63 isoform-driven transcriptional signatures predict tumor progression and clinical outcomes","volume":"78","author":"Abbas","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib129","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/PAS.0000000000001959","article-title":"Dataset for the reporting of merkel cell carcinoma: recommendations from the international collaboration on cancer reporting (ICCR)","volume":"46","author":"Busam","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.03.004_bib130","series-title":"Protocol for the examination of specimens from patients with Merkel cell carcinoma of the skin","author":"Smoller","year":"2021"},{"key":"10.1016\/j.humpath.2023.03.004_bib131","article-title":"Merkel cell carcinoma","author":"Schmults","year":"2022","journal-title":"NCCN Clinical Practice Guidelines in Oncology"},{"key":"10.1016\/j.humpath.2023.03.004_bib132","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.amjsurg.2020.02.018","article-title":"Completion lymph node dissection for Merkel cell carcinoma","volume":"220","author":"Cramer","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.humpath.2023.03.004_bib133","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3390\/cancers13071614","article-title":"Merkel cell carcinoma: new trends","volume":"13","author":"Zwijnenburg","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2023.03.004_bib134","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archderm.142.6.685","article-title":"Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature","volume":"142","author":"Gupta","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.suronc.2017.10.005","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma: the Mayo Clinic experience of 150 patients","volume":"27","author":"Sims","year":"2018","journal-title":"Surg Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib136","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bjd.14240","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases","volume":"174","author":"Gunaratne","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib137","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jaad.2022.01.025","article-title":"Merkel cell carcinoma treatment with Mohs micrographic surgery versus wide local excision: a retrospective cohort survival analysis","volume":"87","author":"Bloomstein","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2023.03.004_bib138","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/12034754221143080","article-title":"Mohs micrographic surgery for facial merkel cell carcinoma","volume":"27","author":"Nguyen","year":"2023","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.humpath.2023.03.004_bib139","doi-asserted-by":"crossref","first-page":"djw042","DOI":"10.1093\/jnci\/djw042","article-title":"Adjuvant radiation therapy and chemotherapy in merkel cell carcinoma: survival analyses of 6908 cases from the national cancer data base","volume":"108","author":"Bhatia","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2023.03.004_bib140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2019.02.015","article-title":"Adjuvant radiotherapy for Merkel cell carcinoma: a systematic\u00a0review and meta-analysis","volume":"134","author":"Petrelli","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib141","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamaoto.2014.3052","article-title":"The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients","volume":"141","author":"Chen","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.humpath.2023.03.004_bib142","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5826\/dpc.0802a15","article-title":"Radiotherapy for inoperable Merkel cell carcinoma: a systematic review and pooled analysis","volume":"8","author":"Patel","year":"2018","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.humpath.2023.03.004_bib143","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejso.2020.05.013","article-title":"Treatment of primary Merkel cell carcinoma: radiotherapy can be an effective, less morbid alternative to surgery","volume":"47","author":"Hong","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib144","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","article-title":"Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma","volume":"5","author":"Iyer","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.humpath.2023.03.004_bib145","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1158\/1078-0432.CCR-17-0439","article-title":"Merkel cell carcinoma in the age of immunotherapy: facts and hopes","volume":"24","author":"Colunga","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib146","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1338237","article-title":"Immune evasion mechanisms and immune checkpoint inhibition in advanced Merkel cell carcinoma","volume":"6","author":"Schadendorf","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.humpath.2023.03.004_bib147","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fonc.2018.00048","article-title":"Merkel cell carcinoma: an update and immunotherapy","volume":"8","author":"Uchi","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib148","article-title":"Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic merkel cell carcinoma: a preplanned interim analysis of a clinical trial","volume":"4","author":"D'Angelo","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib149","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40425-016-0186-1","article-title":"Metastatic Merkel cell carcinoma response to nivolumab","volume":"4","author":"Walocko","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib150","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1158\/1078-0432.CCR-18-4159","article-title":"The genomic landscape of merkel cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy","volume":"25","author":"Knepper","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib151","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000674","article-title":"Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial","volume":"8","author":"D'Angelo","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib152","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002646","article-title":"First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study","volume":"9","author":"D'Angelo","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib153","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1200\/JCO.18.01896","article-title":"Durable tumor regression and overall survival in patients with advanced merkel cell carcinoma receiving pembrolizumab as first-line therapy","volume":"37","author":"Nghiem","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib154","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001076","article-title":"Avelumab for advanced Merkel cell carcinoma in The Netherlands: a real-world cohort","volume":"8","author":"Levy","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib155","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000313","article-title":"Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program","volume":"8","author":"Walker","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2023.03.004_bib156","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1200\/JCO.20.00201","article-title":"Neoadjuvant nivolumab for patients with resectable merkel cell carcinoma in the CheckMate 358 trial","volume":"38","author":"Topalian","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2023.03.004_bib157","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/CMR.0000000000000766","article-title":"Updates on the diagnosis, current and future therapeutic options in Merkel-cell carcinoma","volume":"31","author":"Turshudzhyan","year":"2021","journal-title":"Melanoma Res"},{"key":"10.1016\/j.humpath.2023.03.004_bib158","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jso.25931","article-title":"The association between facility volume and overall survival in patients with Merkel cell carcinoma","volume":"122","author":"Yoshida","year":"2020","journal-title":"J Surg Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723000539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723000539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:42:17Z","timestamp":1758645737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817723000539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":158,"alternative-id":["S0046817723000539"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2023.03.004","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Merkel cell carcinoma: an update","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}